DNLCX
Price
$54.47
Change
+$0.62 (+1.15%)
Updated
Sep 26 closing price
Net Assets
480.79M
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

DNLCX vs VIMSX

Header iconDNLCX vs VIMSX Comparison
Open Charts DNLCX vs VIMSXBanner chart's image
BNY Mellon Active MidCap C
Price$54.47
Change+$0.62 (+1.15%)
VolumeN/A
Net Assets480.79M
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
DNLCX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DNLCX vs. VIMSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLCX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. DNLCX (481M). VIMSX pays higher dividends than DNLCX: VIMSX (1.35) vs DNLCX (0.00). DNLCX was incepted earlier than VIMSX: DNLCX (23 years) vs VIMSX (27 years). DNLCX (2.08) is less costly to investors than VIMSX (0.17). DNLCX is a more actively managed with annual turnover of: 51.78 vs. VIMSX (16.00). DNLCX has a lower initial minimum investment than VIMSX: DNLCX (1000) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. DNLCX (1.27). VIMSX return over 5 years is better than : 70.75 vs. DNLCX (25.19).
DNLCXVIMSXDNLCX / VIMSX
Total Expense Ratio1.750.171,029%
Annual Report Gross Expense Ratio2.080.171,224%
Fund Existence23 years27 years-
Gain YTD7.64810.84571%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets481M199B0%
Annual Yield % from dividends0.001.35-
Returns for 1 year1.2711.5711%
Returns for 3 years35.4455.7464%
Returns for 5 years25.1970.7536%
Returns for 10 years8.97160.666%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LXRX1.400.06
+4.48%
Lexicon Pharmaceuticals
APGE38.220.70
+1.87%
Apogee Therapeutics
ASTS49.09-0.30
-0.61%
AST SpaceMobile
JDZG1.81-0.02
-1.09%
Jiade Limited
LIDR2.36-0.03
-1.26%
AEye